Pseudozyma spp. and Barnettozyma spp. effectively kill cancer cells in vitro  by Hu, Ren-Yu et al.
Genomic Medicine, Biomarkers, and Health Sciences (2012) 4, 61e64Available online at www.sciencedirect.com
journal homepage: www.e-gmbhs.comSHORT COMMUNICATION
Pseudozyma spp. and Barnettozyma spp.
effectively kill cancer cells in vitroRen-Yu Hu, Ching-Fu Lee, Hsiu-Chuan Chou*Department of Applied Science, National Hsinchu University of Education, Hsinchu, Taiwan
Received 11 March 2012; accepted 5 April 2012
Available online 14 May 2012KEYWORDS
cancer cytotoxicity;
lethal yeast;
proteomics* Corresponding author. Department
Hsinchu University of Education, 521
Taiwan.
E-mail address: chouhc@mail.nhcu
2211-4254/$36 Copyright ª 2012, Taiw
doi:10.1016/j.gmbhs.2012.04.015Abstract Cancer is the overall leading cause of death in developed countries and also world-
wide, and being able to exploit an effective anticancer drug is the aim of all cancer scientists.
However, many of the synthetic drugs produced so far usually cause serious side effects, which
reduces their therapeutic efficacy. Discovering new drugs or auxiliary therapies derived from
natural products might thus provide a novel opportunity for cancer therapy. A recent study re-
ported that some lethal toxins can maintain their activity after being injected into mice. We
therefore used two Pseudozyma spp. and three Barnettozyma spp. to examine whether these
killer yeasts can preserve their lethal effect on cancer cells under the physical environment
(optimum pH, temperature and osmolality, supporting a living cell accomplishes to proliferate,
metabolize, differentiate and survive). Our preliminary results showed that both Barnettozy-
ma spp. and Pseudozyma spp. have stronger cytotoxicity against HepG2 than Chang’s liver
cells. According to the results of two-dimensional difference gel electrophoresis (2D-DIGE),
a total of 115 and 27 proteins differentially expressed by 1.5-fold or more were observed
for HepG2 and Chang’s liver cells, respectively. Furthermore, we explored the mechanism
involved in the effect of the lethal yeast filtrates on liver cancer cells using 2D-DIGE and mass
spectrometry.
Copyright ª 2012, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.of Applied Science, National
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Although the chemotherapeutic drugs currently in use have
a good effect in cancer treatment, they also cause side
effects. For example, doxorubicin is toxic to myocardial
cells1 and results in life-threatening heart disease. More-
over, many cancer drugs can generate drug resistance when
they are taken over a long period of time.2 This study aimedrker Society. Published by Elsevier Taiwan LLC. All rights reserved.
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cancer cells but not normal cells, so that the dosage of
standard chemotherapeutic drugs could be reduced while
maintaining the same drug efficacy.
Lethal toxins have been known for many decades,
especially that secreted by the yeast Saccharomyces cer-
evisiae. The lethal mechanism exhibited by competitive
yeasts has been studied quite thoroughly. Interestingly,
recent studies have shown that S. cerevisiae can induce cell
apoptosis after being phagocytosed by cancer cells.3
However, very little is known about the detailed mecha-
nisms underlying the lethal effects of toxins against cancer
cells. This may be because most killer toxins maintain their
activity in a narrow range of temperature and pH value but
lose it in normal physical environments with the tempera-
ture around 37 C and a pH value of 7. In order to obtain and
understand additional information on using these
substances from lethal yeast culture filtrate to treat
cancer, we used two-dimensional difference gel electro-
phoresis (2D-DIGE) and mass spectrometry analysis.Materials and methods
Killer yeasts
The lethal yeast strains we used in this experiment were
three Barnettozyma spp. FN21S02, EN14S14 and GY47S07,
and two Pseudozyma spp., NU22L08 and TE15Z03. The
killer yeasts were inoculated into 500 mL flasks containing
100 mL YPD broth (including 2% glucose, 0.3% yeast
extract, 0.3% malt extract, 0.5% peptone, all chemicals
were purchased from Life Technologies Inc. Gibco branch,
NY, US), and incubated at 25C under agitation for 3 days.
The culture broth was streaked onto YPD plates (YPD
broth with 2% agar). After a few days’ incubation, we
removed a single colony and transferred it into the same
culture broth to isolate the pure lethal yeast strain.Figure 1 Cytotoxic effects of various concentrations of five yeas
control.Cancer cell line
We used human hepatocellular carcinoma cell line HepG2
and nonmalignant Chang’s liver cells to compare the lethal
effect of the yeast filtrates. The cell lines were cultured in
DMEM medium with 10% fetal blood serum and 1% antibiotic
(100 U penicillin and 100 mg/mL streptomycin), and incu-
bated at 37C in an incubator containing 5% carbon dioxide.
MTT assay
MTT assay is a method that tests cell viability. We seeded
8000 cells per well in a 96-well plate, and tested five
different protein concentrations of the culture filtrate for
24 hours. We then added DMSO to dissolve the MTT for-
mazan (the colored reaction product, and is proportional
to cell viability) and measured the absorbance of the
540 nm wavelength.
2D-DIGE analysis
Since most methods of protein visualization, such as two-
dimensional gel electrophoresis, have a narrow linear range
of protein detection, 2D-DIGE, which resolves gel-to-gel
variation, was used in the present study. Three fluorescent
dyes, Cy2, Cy3, and Cy5, were used to label the lysine
residues in the protein samples. The pool of samples was
labeled with Cy2 as a standard for each gel, and labeled
with Cy3 and Cy5 for cross-gel quantitative analysis. The
2D-DIGE image was analyzed using a DeCyder 2D Differen-
tial Analysis Software (GE Healthcare Bio-Sciences AB,
Uppsala, Sweden).
Results
Using MTT assay to determine the cytotoxicity of the five
different culture filtrates, EN14S14 showed a significantt culture filtrates on Chang’s liver cells and HepG2 cells. ctrlZ
Figure 2 Micrograph of the morphology of Chang’s liver cells and HepG2 cells after treatment with 0.01 mg/mL of EN14S14
culture filtrate. Ctrl Z control.
Figure 3 Image of the gel after two-dimensional difference gel electrophoresis. A total of 115 and 27 proteins differentially
expressed by 1.5-fold or more were observed for HepG2 and Chang’s liver cells, respectively. Clearly defined spots assigned
differential expression levels are outlined by a yellow transparent circle; a magenta circle denotes the picking location in the
three-dimensional image view (not shown here).
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cells and HepG2 cells at a treatment concentration of
0.01 mg/mL (Fig. 1). When treated with EN14S14 culture
filtrate (0.01 mg/mL), the morphology of the HepG2 cells
changed so that they became rounded up (Fig. 2). Accord-
ing to the 2D-DIGE results, a total of 115 and 27 proteins
differentially expressed by 1.5-fold or more were observed
for the HepG2 cells and Chang’s liver cells, respectively
(Fig. 3).
Discussion
When body cells die, some materials in their cytoplasm may
influence other healthy cells around them. Therefore, the
chemotherapeutic drugs are expected to induce cell
apoptosis, and not necrosis, during cancer therapy. The
morphological change in the HepG2 cells in the present
study suggested that the culture filtrate might induce
HepG2 cell apoptosis rather than necrosis. In a subsequent
study, we have so far identified more than 50 proteins that
are differentially expressed between lethal yeast filtrate-
treated HepG2 cells and normal cells. Interestingly, several
proteins characterized as apoptotic proteins have corre-
lated with previous reports regarding killer yeast-induced
cancer cell apoptosis.3e6 We are currently using western
blotting, flow cytometry, and immunofluorescence tovalidate these particular biomarkers of apoptosis. Hope-
fully, this study will identify whether certain lethal yeast
filtrates are a potent source of natural substances that will
kill cancer cells without destroying the physical health of
the cancer patients.References
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